Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus (Q46956035)

26 December 2017

title

Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus (English)

1 reference

26 December 2017

1 reference

Ichiro Wakabayashi

1

1 reference

26 December 2017

Hiroshi Masuda

series ordinal

2

1 reference

26 December 2017

publication date

11 October 2007

1 reference

26 December 2017

Journal of Thrombosis and Thrombolysis

published in

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

29-35

1 reference

26 December 2017

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0155-0

Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0155-0

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0155-0

Ultrasonic evaluation of early carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0155-0

Coagulation and fibrinolysis abnormalities in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-007-0155-0

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients

21 January 2018

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

Microalbuminuria in essential hypertension and diabetes mellitus

1 reference

12 December 2020

Protein C activation in NIDDM patients

1 reference

12 December 2020

Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy

1 reference

12 December 2020

What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?

1 reference

12 December 2020

Albuminuria and vascular damage--the vicious twins

1 reference

12 December 2020

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

12 December 2020

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

1 reference

12 December 2020

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

12 December 2020

Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men

1 reference

12 December 2020

Increased plasma thrombin-antithrombin III complex levels in non-insulin dependent diabetic patients with albuminuria are reduced by ethyl icosapentatenoate

1 reference

12 December 2020

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

12 December 2020

Factor VII in non-insulin-dependent diabetic patients with microalbuminuria

1 reference

12 December 2020

Microalbuminuria in diabetic patients: relationship to lipid, glyco-metabolic, coagulation and fibrinolysis parameters

1 reference

12 December 2020

Associations of haemostatic variables with body mass index: a community-based study

1 reference

12 December 2020

Relation of serum sialic acid to blood coagulation activity in type 2 diabetes

1 reference

12 December 2020

Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

12 December 2020

PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria

1 reference

12 December 2020

Obesity, haemostasis and the fibrinolytic system

1 reference

12 December 2020

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

1 reference

12 December 2020

Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

12 December 2020

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

1 reference

12 December 2020

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

1 reference

12 December 2020

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

1 reference

12 December 2020

The effect of microalbuminuria on glycaemic control, serum lipids and haemostasis parameters in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy

1 reference

12 December 2020

Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes

1 reference

12 December 2020

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

1 reference

12 December 2020

10.1007/S11239-007-0155-0

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017